Search

Search Constraints

You searched for: Author/Creator Fryer, Tim D

Search Results

1. [18F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases. Issue 3 (28th August 2021)

2. [18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. Issue 10 (14th September 2017)

3. Amyloid and tau deposition influences cognitive decline in Down syndrome. (31st December 2021)

4. Brain hypoxia mapping in acute stroke: Back-to-back T2′ MR versus 18F-fluoromisonidazole PET in rodents. Issue 7 (October 2017)

5. Diagnostic Utility of Amyloid PET in Cerebral Amyloid Angiopathy-Related Symptomatic Intracerebral Hemorrhage. Issue 5 (May 2014)

6. Diffusion structural network metrics as a predictor for Alzheimer's disease diagnosis in Down syndrome using support vector machine classification: Neuroimaging / Optimal neuroimaging measures for early detection. (7th December 2020)

7. D Atherosclerotic inflammation imaging using 68ga-dotatate pet vs. 18f-fdg pet: a prospective clinical sudy with molecular and histological validation. (5th June 2017)

8. Early striatal amyloid signal in Down Syndrome: Comparison of PiB and Florbetapir PET. (20th December 2022)

9. Early-stage 11C-Flumazenil PET predicts day-14 selective neuronal loss in a rodent model of transient focal cerebral ischemia. Issue 10 (October 2020)

10. Greater aortic inflammation and calcification in abdominal aortic aneurysmal disease than atherosclerosis: a prospective matched cohort study. Issue 1 (11th March 2020)